Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (111-120 of 596) with videos related to

Pageof 60
Sort By:
Seminars in Cancer Biology|November 10, 2020
Next-generation diagnostics for precision oncology: Preanalytical considerations, technical challenges, and available technologiesWencke Walter, Nicole Pfarr, Manja Meggendorfer, et al.
Haematologica|July 6, 2005
Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapyMartin Weisser, Wolfgang Kern, Claudia Schoch, et al.
Genes, Chromosomes & Cancer|April 18, 2019
Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutationsLuise Hartmann, Claudia Haferlach, Manja Meggendorfer, et al.
Leukemia Research|May 31, 2011
Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotypeTorsten Haferlach, Ulrike Bacher, Tamara Alpermann, et al.
Haematologica|August 24, 2011
Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARASusanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Genes, Chromosomes & Cancer|June 8, 2012
Diversity of the juxtamembrane and TKD1 mutations (exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological dataSusanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Haematologica|September 21, 2004
The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroupsClaudia Schoch, Wolfgang Kern, Susanne Schnittger, et al.
Leukemia & Lymphoma|December 29, 2004
Blast count and cytogenetics correlate and are useful parameters for the evaluation of different phases in chronic myeloid leukemiaUlrike Bacher, Wolfgang Kern, Susanne Schnittger, et al.
Cytometry. Part B, Clinical Cytometry|October 7, 2004
Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findingsDaniela Voskova, Claudia Schoch, Susanne Schnittger, et al.
Haematologica|November 12, 2009
Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosisJohanna Flach, Frank Dicker, Susanne Schnittger, et al.
Pageof 60

Showing results (111-120 of 596) with videos related to

Sort By:
Pageof 60
Seminars in Cancer Biology|November 10, 2020
Next-generation diagnostics for precision oncology: Preanalytical considerations, technical challenges, and available technologiesWencke Walter, Nicole Pfarr, Manja Meggendorfer, et al.
Haematologica|July 6, 2005
Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapyMartin Weisser, Wolfgang Kern, Claudia Schoch, et al.
Genes, Chromosomes & Cancer|April 18, 2019
Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutationsLuise Hartmann, Claudia Haferlach, Manja Meggendorfer, et al.
Leukemia Research|May 31, 2011
Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotypeTorsten Haferlach, Ulrike Bacher, Tamara Alpermann, et al.
Haematologica|August 24, 2011
Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARASusanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Genes, Chromosomes & Cancer|June 8, 2012
Diversity of the juxtamembrane and TKD1 mutations (exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological dataSusanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Haematologica|September 21, 2004
The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroupsClaudia Schoch, Wolfgang Kern, Susanne Schnittger, et al.
Leukemia & Lymphoma|December 29, 2004
Blast count and cytogenetics correlate and are useful parameters for the evaluation of different phases in chronic myeloid leukemiaUlrike Bacher, Wolfgang Kern, Susanne Schnittger, et al.
Cytometry. Part B, Clinical Cytometry|October 7, 2004
Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findingsDaniela Voskova, Claudia Schoch, Susanne Schnittger, et al.
Haematologica|November 12, 2009
Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosisJohanna Flach, Frank Dicker, Susanne Schnittger, et al.
Pageof 60